AVE 33.3% 0.2¢ avecho biotechnology limited

success! , page-112

  1. 5,763 Posts.
    lightbulb Created with Sketch. 309
    Its funny Neptune, we are celebrating not so much because the price has gone up(thats nice) we were much higher previously but about the confirmation of what we all beleived. And the path that this opens up across so many opportunities. Several within touching distance now.

    I havent seen any articles explaining why this is so significant.

    POH are just gonna muck around with dosages now, they know plasma levels are in the sweet spot and are so good they can directly attack oral meds as well as patches and for less active and the safety that adds.

    Future trials success are a given.This is not a drug trial.

    The one thing not mentioned was irritation of the skin. This was not an issue with the single patch trial. I wonder if the patch was placed onto the same location each time? I would think patches would be located slightly differently during medical use though.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.